Bronwyn Levvey1, Shaf Keshavjee2, Marcelo Cypel2, Amanda Robinson3, Michael Erasmus4, Allan Glanville5, Peter Hopkins6, Michael Musk7, Marshall Hertz8, Kenneth McCurry9, Dirk Van Raemdonck10, Gregory Snell11. 1. Lung Transplant Service, The Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: b.levvey@alfred.org.au. 2. Toronto Lung Transplant Program, Toronto General Hospital and Hospital for Sick Children, Toronto, Ontario, Canada. 3. United Network for Organ Sharing, Richmond, Virginia, USA. 4. Department of Cardiology and Thoracic Surgery, Universitair Medisch Centrum, Groningen, The Netherlands. 5. Department of Thoracic Medicine and Lung Transplantation, St Vincent's Hospital, Sydney, New South Wales, Australia. 6. Queensland Lung Transplant Service, Prince Charles Hospital, Brisbane, Queensland, Australia. 7. Lung Transplant Unit, Fiona Stanley Hospital, Perth, Western Australia, Australia. 8. Lung Transplant Program, University of Minnesota Medical Center, Minneapolis, Minnesota, USA. 9. Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA. 10. Department of Thoracic Surgery, University Hospitals, Leuven, Belgium. 11. Lung Transplant Service, The Alfred Hospital, Melbourne, Victoria, Australia.
Abstract
BACKGROUND: In this study we aimed to assess the impact of agonal time and warm ischemic time on early survival in Category III donation-after-circulatory-death (DCD) donor lung transplants (LTxs) using data reported to the International Society for Heart and Lung Transplantation (ISHLT) DCD Lung Transplant Registry. METHODS: In this retrospective study, data were analyzed for 507 DCD LTxs done between January 2005 and June 2015. DCD lung donor agonal time (defined as withdrawal of life support to cessation of cardiac output) and warm ischemic time (WIT; defined as donor systolic blood pressure <50 mm Hg to cold pulmonary artery flush) were divided into 3 clinical timing categories (<30 minutes, 30 to 60 minutes, >60 minutes) and 3 tertiles. Univariate analysis was undertaken for all categorizations, and Day 30/Day 365 Kaplan‒Meier survival rates were calculated and compared. Multivariable analysis included Cox proportional hazards regression models to estimate hazard of 365-day mortality. RESULTS: Four hundred sixty-five and 301 DCD LTxs had data to analyze in the agonal and warm ischemic time groups, respectively. Day 30 and Day 365 post-transplant survival overall were 96% and 90%, respectively, and not statistically different according to agonal or WIT category or tertile. CONCLUSIONS: Current experience with DCD Category III LTx does not show a relationship between the duration of donor agonal phase or warm ischemic time up to 60 minutes and early survival. These results suggest the true limits of clinical DCD allograft warm ischemic times may not yet be reached. Global variations in clinical DCD practice are apparent. Continued accurate recording and analyses of DCD processes is warranted.
BACKGROUND: In this study we aimed to assess the impact of agonal time and warm ischemic time on early survival in Category III donation-after-circulatory-death (DCD) donor lung transplants (LTxs) using data reported to the International Society for Heart and Lung Transplantation (ISHLT) DCD Lung Transplant Registry. METHODS: In this retrospective study, data were analyzed for 507 DCD LTxs done between January 2005 and June 2015. DCD lung donor agonal time (defined as withdrawal of life support to cessation of cardiac output) and warm ischemic time (WIT; defined as donor systolic blood pressure <50 mm Hg to cold pulmonary artery flush) were divided into 3 clinical timing categories (<30 minutes, 30 to 60 minutes, >60 minutes) and 3 tertiles. Univariate analysis was undertaken for all categorizations, and Day 30/Day 365 Kaplan‒Meier survival rates were calculated and compared. Multivariable analysis included Cox proportional hazards regression models to estimate hazard of 365-day mortality. RESULTS: Four hundred sixty-five and 301 DCD LTxs had data to analyze in the agonal and warm ischemic time groups, respectively. Day 30 and Day 365 post-transplant survival overall were 96% and 90%, respectively, and not statistically different according to agonal or WIT category or tertile. CONCLUSIONS: Current experience with DCD Category III LTx does not show a relationship between the duration of donor agonal phase or warm ischemic time up to 60 minutes and early survival. These results suggest the true limits of clinical DCD allograft warm ischemic times may not yet be reached. Global variations in clinical DCD practice are apparent. Continued accurate recording and analyses of DCD processes is warranted.
Authors: Andreas H Kramer; Kerry Holliday; Sean Keenan; George Isac; Demetrios J Kutsogiannis; Norman M Kneteman; Adrian Robertson; Peter Nickerson; Lee Anne Tibbles Journal: Can J Anaesth Date: 2020-02-25 Impact factor: 5.063
Authors: Pedro Augusto Reck Dos Santos; Paulo José Zimermann Teixeira; Daniel Messias de Moraes Neto; Marcelo Cypel Journal: J Bras Pneumol Date: 2022-04-20 Impact factor: 2.800
Authors: Beatriz Domínguez-Gil; Nancy Ascher; Alexander M Capron; Dale Gardiner; Alexander R Manara; James L Bernat; Eduardo Miñambres; Jeffrey M Singh; Robert J Porte; James F Markmann; Kumud Dhital; Didier Ledoux; Constantino Fondevila; Sarah Hosgood; Dirk Van Raemdonck; Shaf Keshavjee; James Dubois; Andrew McGee; Galen V Henderson; Alexandra K Glazier; Stefan G Tullius; Sam D Shemie; Francis L Delmonico Journal: Intensive Care Med Date: 2021-02-26 Impact factor: 17.440
Authors: Christopher M Bobba; Bryan A Whitson; Matthew C Henn; Nahush A Mokadam; Brian C Keller; Justin Rosenheck; Asvin M Ganapathi Journal: Transpl Int Date: 2022-04-04 Impact factor: 3.842